Issue 1-2/2005
Content (13 Articles)
Part I HIV-1 Asociated Dementia (HAD)
The AIDS dementia complex: Clinical and basic Neuroscience with implications for novel molecular therapies
Bradford A. Navia, Kevin Rostasy
Part I HIV-1 Asociated Dementia (HAD)
Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases
Irena Kadiu, Jason G. Glanzer, Jonathan Kipnis, Howard E. Gendelman, Mark P. Thomas
Part I HIV-1 Asociated Dementia (HAD)
The shifting patterns of HIV encephalitis neuropathology
Ian P. Everall, Lawrence A. Hansen, Eliezer Masliah
Part I HIV-1 Asociated Dementia (HAD)
Molecular targets of opiate drug abuse in neuro AIDS
Kurt F. Hauser, Nazira El-Hage, Shreya Buch, Joseph R. Berger, William R. Tyor, Avindra Nath, Annadora J. Bruce-Keller, Pamela E. Knapp
Part II Experimental Models of Had
Human brain derived cell culture models of HIV-1 infection
Pankaj Seth, Eugene O. Major
Part II Experimental Models of Had
Rodent model systems for studies of HIV-1 associated dementia
Yuri Persidsky, Raghava Potula, James Haorah
Part II Experimental Models of Had
The role of monocytes and perivascular macrophages in HIV and SIV neuropathogenesis: Information from non-human primate models
Woong-Ki Kim, Xavier Alvarez, Kenneth Williams
Part III Molecular and Cellular Mechanisms of Neuronal Cell Death
Molecular and cellular mechanisms of neuronal cell death in HIV dementia
W. Li, D. Galey, Mark P. Mattson, Avindra Nath
Part III Molecular and Cellular Mechanisms of Neuronal Cell Death
The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia
Y. Huang, N. Erdmann, J. Zhao, J. Zheng
Part III Molecular and Cellular Mechanisms of Neuronal Cell Death
HIV-1, chemokines and neurogenesis
Phuong B. Tran, Richard J. Miller
Part IV Neuroprotective Agents
Adjunctive therapies for HIV-1 associated neurologic disease
Seth W. Perry, John P. Norman, Harris A. Gelbard
Part IV Neuroprotective Agents
Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin
Marcus Kaul, Stuart A. Lipton
Part IV Neuroprotective Agents
Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration
Rachel L. Nosheny, Italo Mocchetti, Alessia Bachis